These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36402792)

  • 1. Gut microbiota analysis for prediction of clinical relapse in Crohn's disease.
    Buffet-Bataillon S; Bouguen G; Fleury F; Cattoir V; Le Cunff Y
    Sci Rep; 2022 Nov; 12(1):19929. PubMed ID: 36402792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
    J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease recurrence updates: first surgery
    Russo E; Cinci L; Di Gloria L; Baldi S; D'Ambrosio M; Nannini G; Bigagli E; Curini L; Pallecchi M; Andrea Arcese D; Scaringi S; Malentacchi C; Bartolucci G; Ramazzotti M; Luceri C; Amedei A; Giudici F
    Front Immunol; 2022; 13():886468. PubMed ID: 35967326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
    World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
    Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
    Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.
    Elzayat H; Malik T; Al-Awadhi H; Taha M; Elghazali G; Al-Marzooq F
    Sci Rep; 2023 Nov; 13(1):19198. PubMed ID: 37932491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn's disease.
    Hu J; Cheng S; Yao J; Lin X; Li Y; Wang W; Weng J; Zou Y; Zhu L; Zhi M
    Front Immunol; 2022; 13():947313. PubMed ID: 36045690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease.
    He C; Wang H; Yu C; Peng C; Shu X; Liao W; Zhu Z
    Front Bioeng Biotechnol; 2021; 9():673691. PubMed ID: 34295880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn's disease - a preliminary study.
    Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Niemira M; Zeber-Lubecka N; Zagorowicz E; Kretowski A; Ostrowski J
    BMC Gastroenterol; 2020 Sep; 20(1):307. PubMed ID: 32958038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
    Basson AR; Gomez-Nguyen A; Menghini P; Buttó LF; Di Martino L; Aladyshkina N; Osme A; LaSalla A; Fischer D; Ezeji JC; Erkkila HL; Brennan CJ; Lam M; Rodriguez-Palacios A; Cominelli F
    Inflamm Bowel Dis; 2020 Feb; 26(3):347-359. PubMed ID: 31750921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders.
    Bojović K; Ignjatović ÐI; Soković Bajić S; Vojnović Milutinović D; Tomić M; Golić N; Tolinački M
    Front Cell Infect Microbiol; 2020; 10():223. PubMed ID: 32509596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
    Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.
    Rajca S; Grondin V; Louis E; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Paintaud G; Piver E; Allez M; Mary JY; Sokol H; Colombel JF; Seksik P
    Inflamm Bowel Dis; 2014 Jun; 20(6):978-86. PubMed ID: 24788220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease.
    Jiang J; Chen L; Chen Y; Chen H
    BMC Gastroenterol; 2022 Apr; 22(1):212. PubMed ID: 35501724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
    Klaassen MAY; Imhann F; Collij V; Fu J; Wijmenga C; Zhernakova A; Dijkstra G; Festen EAM; Gacesa R; Vich Vila A; Weersma RK
    J Crohns Colitis; 2019 Oct; 13(11):1439-1449. PubMed ID: 31066440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.